Company / Operating Cash Flow
InMed Pharmaceuticals Inc. Operating Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$7.0M
FY2025
5-year range
-$15.6M / -$7.0M
FY2022-FY2025
Trend
+4.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$16M to -$7M over the past 2 years.
Based on SEC 10-K filings.
-$7M in FY2025.
Improved from -$16M to -$7M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 4.1% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.0M | +4.1% |
| FY2024 | -$7.3M | +53.3% |
| FY2023 | -$15.6M | -59.2% |
| FY2022 | -$9.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026